Label Changes for:

Lysteda (tranexamic acid) Tablets

April 2011

Changes have been made to the WARNINGS and PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – April 2011

 

5 WARNINGS AND PRECAUTIONS

5.1 thromboembolic Risk
  • ...Concomittant Use of Hormonal Contraceptives...
5.4 Ligneous Conjunctivitis
  • section added
Advertisement
Close

Recommended

(web5)